Your partner in preparing for a global Series A

You build the science. We build the Series A case.

What the Hb-022 team helps clients with:

Defensible IP, a credible regulatory path, faster routes to value, and a valuation investors can defend — engineered before the data room opens. Explore our case studies to find out more.

Start with a Readiness Diagnostic See what investors will ask →

25 years in pharma & biotech
6 startups · multiple exits
US · India · Europe